Zenotech Laboratories has received approval from the US Food and Drug Administration (USFDA) for its ondansetron injection, a copy of Glaxosmithkline Plc’s Zofran anti-nausea medicine.
Zenotech develops and manufactures generic bio-pharmaceuticals and markets them to people with unmet medical needs around the world. The company aims to bring a constant pipeline of new biogeneric products to the market. The highly qualified and trained staff uses recombinant DNA technology and cGMP production methods to give the customers generic versions of biotherapeutic drugs comparable to the innovator product in quality, safety and efficacy.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1874.30 |
| Dr. Reddys Lab | 1297.00 |
| Cipla | 1317.60 |
| Zydus Lifesciences | 944.10 |
| Lupin | 2262.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: